[{"Physician_Profile_ID": "251998", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Gilead Sciences Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000108", "Total_Amount_of_Payment_USDollars": "113.14", "Date_of_Payment": "12/22/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "168221408", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "764029-1878104-8034975 - 1660433 - 30041161-1660433-Gilead Sciences-VRL"}, {"Physician_Profile_ID": "251998", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Pfizer Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000286", "Total_Amount_of_Payment_USDollars": "92.10", "Date_of_Payment": "08/12/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "206497058", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ELIQUIS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "251998", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "32.50", "Date_of_Payment": "05/29/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "290785172", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SPIRIVA", "Name_of_Associated_Covered_Drug_or_Biological2": "Respimat", "Contextual_Information": ""}, {"Physician_Profile_ID": "251998", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "20.31", "Date_of_Payment": "02/14/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "194086622", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Brintellix", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "251998", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novo Nordisk Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000144", "Total_Amount_of_Payment_USDollars": "18.63", "Date_of_Payment": "08/22/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "161851234", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Levemir", "Name_of_Associated_Covered_Drug_or_Biological2": "Victoza", "Contextual_Information": ""}, {"Physician_Profile_ID": "251998", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novo Nordisk Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000144", "Total_Amount_of_Payment_USDollars": "18.21", "Date_of_Payment": "09/04/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "266969202", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Saxenda", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "251998", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "18.19", "Date_of_Payment": "05/26/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "194086626", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Nesina", "Name_of_Associated_Covered_Drug_or_Biological2": "Oseni", "Contextual_Information": ""}, {"Physician_Profile_ID": "251998", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "17.50", "Date_of_Payment": "04/03/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "295169376", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Myrbetriq", "Name_of_Associated_Covered_Drug_or_Biological2": "Vesicare", "Contextual_Information": ""}, {"Physician_Profile_ID": "251998", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Iroko Pharmaceuticals, LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000011114", "Total_Amount_of_Payment_USDollars": "17.25", "Date_of_Payment": "01/09/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "338518154", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ZORVOLEX", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "251998", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Iroko Pharmaceuticals, LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000011114", "Total_Amount_of_Payment_USDollars": "17.25", "Date_of_Payment": "01/09/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "338518158", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ZORVOLEX", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "251998", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "17.16", "Date_of_Payment": "04/25/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "158836802", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "RELISTOR", "Name_of_Associated_Covered_Drug_or_Biological2": "XIFAXAN 550 MG TABLETS", "Contextual_Information": ""}, {"Physician_Profile_ID": "251998", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "16.87", "Date_of_Payment": "07/25/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "275329168", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xarelto", "Name_of_Associated_Covered_Drug_or_Biological2": "Invokana", "Contextual_Information": "Related to product discussion"}, {"Physician_Profile_ID": "251998", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Pfizer Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000286", "Total_Amount_of_Payment_USDollars": "16.49", "Date_of_Payment": "12/13/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "205444668", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ZYVOX", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "251998", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "16.10", "Date_of_Payment": "12/18/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "295076422", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Myrbetriq", "Name_of_Associated_Covered_Drug_or_Biological2": "Vesicare", "Contextual_Information": ""}, {"Physician_Profile_ID": "251998", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "15.44", "Date_of_Payment": "09/17/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "104414238", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "PRADAXA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "251998", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novo Nordisk Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000144", "Total_Amount_of_Payment_USDollars": "15.40", "Date_of_Payment": "06/18/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "266842368", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Levemir", "Name_of_Associated_Covered_Drug_or_Biological2": "Victoza", "Contextual_Information": ""}, {"Physician_Profile_ID": "251998", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Pfizer Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000286", "Total_Amount_of_Payment_USDollars": "15.39", "Date_of_Payment": "10/30/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "323754876", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "CHANTIX", "Name_of_Associated_Covered_Drug_or_Biological2": "VIAGRA", "Contextual_Information": ""}, {"Physician_Profile_ID": "251998", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AstraZeneca Pharmaceuticals LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "DE", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000146", "Total_Amount_of_Payment_USDollars": "14.44", "Date_of_Payment": "02/21/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "148554060", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "BYDUREON", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Informational Meal"}, {"Physician_Profile_ID": "251998", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "14.33", "Date_of_Payment": "08/01/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "194086624", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Brintellix", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "251998", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novo Nordisk Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000144", "Total_Amount_of_Payment_USDollars": "14.23", "Date_of_Payment": "04/17/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "161192260", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Levemir", "Name_of_Associated_Covered_Drug_or_Biological2": "Victoza", "Contextual_Information": ""}, {"Physician_Profile_ID": "251998", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novo Nordisk Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000144", "Total_Amount_of_Payment_USDollars": "14.04", "Date_of_Payment": "10/25/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "32248838", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "NovoLog", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "251998", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novo Nordisk Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000144", "Total_Amount_of_Payment_USDollars": "13.64", "Date_of_Payment": "04/13/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "266609800", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Levemir", "Name_of_Associated_Covered_Drug_or_Biological2": "Victoza", "Contextual_Information": ""}, {"Physician_Profile_ID": "251998", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Pfizer Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000286", "Total_Amount_of_Payment_USDollars": "13.56", "Date_of_Payment": "03/28/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "322716178", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "VIAGRA", "Name_of_Associated_Covered_Drug_or_Biological2": "ELIQUIS", "Contextual_Information": ""}, {"Physician_Profile_ID": "251998", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "13.54", "Date_of_Payment": "09/18/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "290785168", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "JARDIANCE", "Name_of_Associated_Covered_Drug_or_Biological2": "GLYXAMBI", "Contextual_Information": ""}, {"Physician_Profile_ID": "251998", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "13.41", "Date_of_Payment": "08/02/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "23817145", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xarelto", "Name_of_Associated_Covered_Drug_or_Biological2": "Invokana", "Contextual_Information": ""}, {"Physician_Profile_ID": "251998", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Amgen Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000203", "Total_Amount_of_Payment_USDollars": "13.02", "Date_of_Payment": "11/20/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "297536558", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Prolia", "Name_of_Associated_Covered_Drug_or_Biological2": "Repatha", "Contextual_Information": ""}, {"Physician_Profile_ID": "251998", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Lilly USA, LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IN", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000066", "Total_Amount_of_Payment_USDollars": "12.29", "Date_of_Payment": "02/16/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "267924112", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "TRULICITY", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "251998", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "12.03", "Date_of_Payment": "10/03/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "156354938", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xarelto", "Name_of_Associated_Covered_Drug_or_Biological2": "Invokana", "Contextual_Information": ""}, {"Physician_Profile_ID": "251998", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "12.02", "Date_of_Payment": "07/11/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "156354942", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "251998", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AstraZeneca Pharmaceuticals LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "DE", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000146", "Total_Amount_of_Payment_USDollars": "11.95", "Date_of_Payment": "12/19/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "227721234", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "BYDUREON WEEKLY", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Informational Meal"}, {"Physician_Profile_ID": "251998", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novo Nordisk Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000144", "Total_Amount_of_Payment_USDollars": "11.88", "Date_of_Payment": "03/07/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "160987688", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Levemir", "Name_of_Associated_Covered_Drug_or_Biological2": "Victoza", "Contextual_Information": ""}, {"Physician_Profile_ID": "251998", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Auxilium Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010522", "Total_Amount_of_Payment_USDollars": "11.70", "Date_of_Payment": "06/20/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "212037462", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "STENDRA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "251998", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "10.38", "Date_of_Payment": "08/23/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "24084563", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "EXELON PATCH", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "251998", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "0.43", "Date_of_Payment": "10/03/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "156354940", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xarelto", "Name_of_Associated_Covered_Drug_or_Biological2": "Invokana", "Contextual_Information": ""}]